gip glp 1 agonist tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction GLP-1/GIP dual agonist tirzepatide alleviates

Neuen BL, Oshima M, Agarwal R, Arnott C, Cherney DZ, Edwards R, et al

For example, resistant starches, which are found in foods such as potatoes, unripe bananas, tigernuts, and Jerusalem artichokes, resist digestion in the small intestine and reach the large intestine, where they are fermented, generating their beneficial effects

Arterioscler Thromb

Graham et al., 2020)

Tirzepatide and semaglutide performed similarly - so the impact on heart failure was not directly correlated to weight loss

This is an extensive consultation process that includes WADAs List Expert Advisory Group gathering information including the latest scientific and medical research, trends, and intelligence gathered from law enforcement and pharmaceutical companies